Cell Therapeutics [CTIC] 第3贴。..

@.@MiKeY@.@

CTIC怎么了？为什么没交易？

roberto

回复 81# @.@MiKeY@.@


Cell Therapeutics, Inc. (NASDAQ: CTIC) 8.8% LOWER;Notice is hereby given that Glancy Binkow & Goldberg LLP has fileda class action lawsuit in the United States District Court for theWestern District of Washington on behalf of a class consisting of allpersons or entities who purchased the common stock of Cell Therapeuticsbetween May 5, 2009 and February 8, 2010, inclusive.

pink0905

有那种不好的感觉。

pink0905

有那种不好的感觉。
有谁知道什么时候开市？

韦一笑

好像是reject了是吗？

韦一笑

有那种不好的感觉。
有谁知道什么时候开市？
pink0905 发表于 22-3-2010 11:18 PM

你有什么看法？

pink0905

回复 86# 韦一笑


    没有看法。。。
等亏钱！！！！！！１１

pink0905

分姐在这里妈？
想问你有什么看法？

pink0905

Panel votes 9-0 that company trial was inadequate

* FDA usually follows panel recommendations

GAITHERSBURG, Md., March 22 (Reuters) - Cell Therapeutics Inc (CTIC.O) has not collected enough data on an experimental lymphoma drug to win U.S. approval, a government advisory panel unanimously said on Monday.

Advisers to the Food and Drug Administration, in a 9-0 vote, said the company's single trial was not adequate to support approval of the drug, pixantrone.

Seattle-based Cell Therapeutics is seeking FDA clearance to sell pixantrone under the name Pixuvri for treating non-Hodgkin's lymphoma that has stopped responding to other treatments.

The final decision rests with the FDA, but the agency usually follows panel recommendations. An FDA ruling is due by April 23.

Cell Therapeutics' shares were halted on Nasdaq while the panel met. (Reporting by Lisa Richwine, editing by Maureen Bavdek)

韦一笑

如果要卖的话，现在可以卖吗？

pink0905

回复 90# 韦一笑


    开市３！
你买很多？

roberto

On Monday March 22, 2010, 4:35 pm EDT


NEW YORK (AP) -- Shares of Cell Therapeutics Inc. tumbled Monday after a government advisory panel said there is not enough scientific evidence to justify approving the company's lymphoma drug candidate.                        
A cancer drug advisory panel unanimously recommended against approving the drug candidate pixantrone, the Seattle company said. The Food and Drug Administration is not required to follow the advice of its panels, but it often does so, and the vote appears to diminish the drug's chances for approval.
The company is seeking approval to market pixantrone as a treatment for non-Hodgkin's lymphoma in patients whose cancer has progressed despite treatment with at least two other therapies.
The FDA is scheduled to make a decision on the drug by April 23.
Shares of Cell Therapeutics lost 44 cents, or 48 percent, to close at 47 cents Monday. Trading had been halted until the early afternoon. The stock has ranged between 11 cents and $2.23 over the last year.

bennywt

我又再进了。$0.12@1000
让他去冬眠了。。。

kelvin2080

$0.12 你都买到？？？ 利害。。。 为甚么不买多点呢？？

bennywt

$0.12 你都买到？？？ 利害。。。 为甚么不买多点呢？？
kelvin2080 发表于 23-3-2010 10:23 AM

不敢投机。。。看好opaxio这个药，打算长收。
而且，我其实也不知道如何买到，昨晚11点多，我看到他on halt，我就放$0.30 @ 1000，然后就去睡。早上看到email，我买到$0.12 @1000。。。

jjc2

我又再进了。$0.12@1000
让他去冬眠了。。。
bennywt 发表于 23-3-2010 10:14 AM

    $0.12 是昨晚的最低点你都买到?利害！
你已经赚好几倍了。。

kelvin2080

如果跌到0.30， 我也会买几粒长收。不错的。。

葉芬

分姐在这里妈？
想问你有什么看法？
pink0905 发表于 23-3-2010 12:34 AM

只好Hold著，反正都Hold了這么久了。

價錢跌得太低，沒有必要放。


Cell Therapeutics Looking More Like Sell Therapeutics (CTIC)   
                                                        March 22, 2010 · Filed Under Cancer,  Financial,  fda



Cell Therapeutics, Inc. (NASDAQ: CTIC) is about to get to show traders and speculative investors the pleasure and pain in the world of chasing ten-baggersin speculative biotech stocks.  The stock has developed a cultfollowing, as you would expect in a company with a share price under$1.00 and a market cap of $560 million.  Shares were halted at 7:00 AMEST this morning and it seems that we are finding out why the suddendrop came late Friday afternoon.


We noted last month how the company was facing a much tougher FDAand that appears to have been the case.  The FDA has just rejected itsNDA…. saying there was not enough clinical evidence to show whether thedrug worked.  There has yet to be an official press release from thecompany at noon, although it is spreading around the web.  The vote was9 to 0 against the drug.


It is developing pixantrone, its Phase III single-agent clinicaltrial product as a treatment for non-Hodgkins lymphoma and variousother hematologic malignancies, solid tumors, and immunologicaldisorders. It was just on March 8 when the company announced that theFDA approved NerPharMa to manufacture Cell Therapeutics’ drugPixantrone.



What is interesting is that this wasindicated to treat non-Hodgkin’s lymphoma patients whose disease hasprogressed after treatment with at least two other therapies.  This isnot an outright death of the drug.  But this throws a long delay and along fight ahead for Cell Therapeutics.  There have been troubles inrecruiting new patients and that caused the main study to be dropped. The original goal was 320 patients, but only 140 enrolled.


On March 1 the company issued news that the FDA had set March 22 forthe ODAC Meeting to review CTI’s New Drug Application for Pixantrone. That may have been one of the culprits in the trading and investingcommunity believing that an ultimate FDA approval would come its way. On March 1 it was a $0.70 stock, and it was at $1.03 Friday before alate-day selling round took shares down to $0.91.
On March 8 it hit an intra-day high of $1.25 before selling off, andthe trading volume has been quite elevated.  To show how volatile thisone is, the 52-week trading range is $0.12 to $2.23.


There has also been a discrepancy over what the company says is statically significant versus what the FDA measures.


This stock is no stranger to class action lawsuits.  We saw a classaction filing on Friday from Glancy Binkow & Goldberg LLP… andinvestigation announcement by Robbins Umeda LLP last Tuesday…. a classaction from Dyer & Berens LLP last Monday… and a class action fromIzard Nobel LLP also last Monday.


The company has set a special meeting of shareholders for Friday,April 9, 2010.  It is going to be a special meeting, that much is forsure.


News came out on Dow Jones in a headline at 11:25 AM EST that theFDA panel rejected Pixantrone, and the chat rooms and message boardshave been active since 11 AM.  No resumption time has yet been set byNASDAQ.  The Street.com also has been live-blogging the eventand that is worth a read if you want to smooth out the pros and consand the bulls and bears who have bet for or against the stock.


This has been asked before and as always the answer is the same… “No, I hold no long or short position in this stock.”

UPDATE II: At 1:40 PM EST this resumed and shares were down 67% at $0.30 on over 14 million shares by 1:41 PM EST.

UPDATE: SHARES WILL RESUME TRADING PER NASDAQ DATA AT 1:40 PM EST.






   

葉芬

不敢投机。。。看好opaxio这个药，打算长收。
而且，我其实也不知道如何买到，昨晚11点多，我看到他on ...
bennywt 发表于 23-3-2010 10:35 AM

恭喜。 0.12 都給你買到。

葉芬

轉帖：分享。
讓你們知道下股價在大跌時是這樣子買到更便宜的股。
如bennywt排0.30，卻買到更便宜的0.12


I hope everyone reading this thread realizes that there were a ton of people that got their accounts annihilated today, but they are not posting about it, probably because it hurts too much.

So let's say these people bought at 1.00 or something ridiculous like 1.20 a week or 2 ago.

Now, the stock was halted all day, and then the rejection news came out.
Alot of people panicked, while this was halted, and probably put in stop loss orders, lets say at 75 cents.

What they may not have realized is that once the price of CTIC was below 0.75, that stop loss turned into a MARKET SELL ORDER. Which means that, since CTIC opened at 0.35, or whatever, it was, all those orders turned into one GIGANTIC market sell order, which was to the tune of probably 5 million shares, if you look at the chart. The price dropped all the way down to 0.12, and I am sure that a ton of people got their stop losses filled at sells of lets say 0.15 or 0.17 from their buy of 1.20$. Instant account annihilation, if they were unfortunate enough to over allocate, which many were, judging by how bullish and deluded the various CTIC message boards were.

And of course, there was immediate short covering on that news, and CTIC ran up to ~0.50. A wild, wild day, and we should all say a prayer for the CTIC longs who were annihilated today.